Now Available On-Demand!
Did you miss the live event held on October 24, 2024? You can still register for the on-demand content!
Chair
René H. Gifford, PhD
Fred H. Bess Chair in Audiology, Professor, and Director, Hearing and Speech Sciences, Implantables, Hearing Enhancement, and Amplification Research (I HEAR) Laboratory Vanderbilt University Medical Center
Program Committee
- Camille Dunn-Johnson, PhD
Associate Professor and Director of the Cochlear Implant Program, University of Iowa - Michelle Hughes, PhD
Professor and Director of the Cochlear Implant Research Lab, University of Nebraska, Lincoln - Jamie Bogle, AuD, PhD
Principal Investigator, ARC Grant, Chair, Division of Audiology and Assistant Professor, Mayo Clinic College of Medicine Science
Conference Overview
There’s a 17- to 25-year gap between scientific discovery and clinical adoption of new and effective interventions. For children with congenital hearing loss, a two-decade delay for data-driven advancements in diagnostic and habilitative audiological practices can have devastating effects on auditory, speech, language, academic, and social development. Adults with hearing loss also are at risk for impaired communication, social isolation, educational and vocational barriers, dementia, and poor quality of life. Since auditory implantable technology is rapidly advancing, and candidacy indications are both expanding and overlapping, attempting to stay up-to-date on the literature becomes a part-time job, which is particularly difficult for full-time clinicians.
The 2024 Virtual Academy Research Conference (ARC) will bring together the latest discovery in auditory implantable technology from an esteemed group of clinician-scientists in audiology and otology. We will be covering topics including advances in auditory implant surgery, asymmetrically driven neuroplasticity for bimodal and sequential bilateral cochlear implant (CI) recipients, the role of genetics in clinical decision-making for candidacy determination and recommended intervention, totally implantable technology, single-sided deafness (SSD), highly asymmetric hearing losses, and much more.
Program
- Morning Session 10:00 am–12:30 pm ET
- Afternoon Session 1:00–3:30 pm ET
- CEUs:
.25 Tier 1 CEUs for morning or afternoon session
.5 Tier 1 CEUs for full-day program
Registration
Available for half-day, full-day, or on-demand only.
| Category | ARC 2024 Fee |
| Member Half-Day | $89 |
| Member Full-Day | $135 |
| Non-Member Half-Day | $150 |
| Non-Member Full-Day | $240 |
| Student Half-Day | $25 |
| Student Full-Day | $45 |
Funding for this conference was made possible [in part] by 1R13DC020893-01 from National Institute of Deafness and Other Communication Disorders.
Now Available On-Demand!
Did you miss the live event held on October 24, 2024? You can still register for the on-demand content!
Chair
René H. Gifford, PhD
Fred H. Bess Chair in Audiology, Professor, and Director, Hearing and Speech Sciences, Implantables, Hearing Enhancement, and Amplification Research (I HEAR) Laboratory Vanderbilt University Medical Center
Program Committee
- Camille Dunn-Johnson, PhD
Associate Professor and Director of the Cochlear Implant Program, University of Iowa - Michelle Hughes, PhD
Professor and Director of the Cochlear Implant Research Lab, University of Nebraska, Lincoln - Jamie Bogle, AuD, PhD
Principal Investigator, ARC Grant, Chair, Division of Audiology and Assistant Professor, Mayo Clinic College of Medicine Science
Conference Overview
There’s a 17- to 25-year gap between scientific discovery and clinical adoption of new and effective interventions. For children with congenital hearing loss, a two-decade delay for data-driven advancements in diagnostic and habilitative audiological practices can have devastating effects on auditory, speech, language, academic, and social development. Adults with hearing loss also are at risk for impaired communication, social isolation, educational and vocational barriers, dementia, and poor quality of life. Since auditory implantable technology is rapidly advancing, and candidacy indications are both expanding and overlapping, attempting to stay up-to-date on the literature becomes a part-time job, which is particularly difficult for full-time clinicians.
The 2024 Virtual Academy Research Conference (ARC) will bring together the latest discovery in auditory implantable technology from an esteemed group of clinician-scientists in audiology and otology. We will be covering topics including advances in auditory implant surgery, asymmetrically driven neuroplasticity for bimodal and sequential bilateral cochlear implant (CI) recipients, the role of genetics in clinical decision-making for candidacy determination and recommended intervention, totally implantable technology, single-sided deafness (SSD), highly asymmetric hearing losses, and much more.
Program
- Morning Session 10:00 am–12:30 pm ET
- Afternoon Session 1:00–3:30 pm ET
- CEUs:
.25 Tier 1 CEUs for morning or afternoon session
.5 Tier 1 CEUs for full-day program
Registration
Available for half-day, full-day, or on-demand only.
| Category | ARC 2024 Fee |
| Member Half-Day | $89 |
| Member Full-Day | $135 |
| Non-Member Half-Day | $150 |
| Non-Member Full-Day | $240 |
| Student Half-Day | $25 |
| Student Full-Day | $45 |
Funding for this conference was made possible [in part] by 1R13DC020893-01 from National Institute of Deafness and Other Communication Disorders.
More Events
The One Percent: Working with Complex Tinnitus Patients
Presenters: Emily McMahan, AuD Gail Whitelaw, PhD CEUs: 0.1 AAA / Tier 1 CEUs Duration: 60 minutes Instructional…
Read More
Unveiling the Truth About Cochlear Implants
Presenter: Meredith Holcomb, AuD CEUs: 0.1 AAA / Tier 1 CEUs Duration: 60 minutes Instructional Level: Intermediate Program Focus: Knowledge Description: The utilization rate for cochlear…
Read More
